| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | Nov 14, 2025 | ARS Pharmaceuticals, Inc. | COO | Sell | 22.5 | -21,828 | -66.92% | ✗ | $190K |
| Dec 11, 2024 | Dec 13, 2024 | ARS Pharmaceuticals, Inc. | COO | Sell | 7.5 | -40,000 | -76.85% | ✓ | $493.9K |
| Aug 20, 2024 | Aug 21, 2024 | ARS Pharmaceuticals, Inc. | COO | Sell | 7.5 | -50,000 | -89.25% | ✓ | $750K |
| Aug 13, 2024 | Aug 15, 2024 | ARS Pharmaceuticals, Inc. | COO | Sell | 7.5 | -30,000 | -83.28% | ✓ | $390K |